Jump to any asset
850 assets, updated daily
As of September 11, 2026, ASP Isotopes Inc. (ASPI) trades at $3.59. CleaRank Financial AI rates it Buy with a fair value of $3.59, in line with the current price. Wall Street's consensus target is $13.00 across 3 analysts. RSI at 41 is in neutral territory, and the price is below its 50-day average of $4.25.
ASP Isotopes Inc. (ASPI)
ASP Isotopes Inc. NASDAQ
$3.59
-0.2300 (-6.02%)
Latest Price
AI Analyst Consensus
75 / 100
ASP Isotopes Inc. (ASPI) is trading at $3.59, below its 50-day and 200-day moving averages ($4.25 and $5.49), indicating a bearish short-term technical trend. Despite this, Wall Street maintains a strong Buy consensus with a median price target of $13.00, suggesting substantial upside potential. The company is projected to experience significant revenue growth, with next year's estimates showing a 275.00% increase, albeit from a low base and with current year revenue expected to decline by 8.00%. While EPS remains negative at -1.44, the most recent earnings report showed a 35.9% positive surprise on EPS estimates. A key risk remains the moderate insider selling, with $19.6 million in sales versus no purchases, signaling potential caution from management.
ASPI Price Analysis
Market Metrics
Open
$3.76
Day Range
$3.58 to $3.83
Prev Close
$3.82
Volume
5.04M
52-Week Range
$3.51 to $14.49
Market Cap
$550.38M
Peer Benchmarking
Valuation vs Sector (Basic Materials)
Performance vs XLB
Sector Position Analysis
On price-to-sales, the yardstick used here in place of P/E, ASPI trades at 17.84x, far above the sector average of 4.20x.
ASPI Financial Performance
Revenue vs. Earnings
Annual
Quarterly
Earnings Reality Check
Analysis: In the last 4 quarters, ASPI beat estimates 2 times. However, the stock fell 2 times the next day. This suggests positive news is often "priced in" or investors are selling the news.
ASPI Analysis
Company's Health
3/5
AI Technical Analysis
ASP Isotopes Inc. (ASPI) is currently trading below its key moving averages, with its price below the 50-day SMA of $4.25 and the 200-day SMA of $5.49. The RSI is at 41.39, indicating neutral momentum, while the MACD is slightly negative at -0.128. The stock has experienced significant volume recently, with current volume at 5,041,800, which is 46.9% above its average volume. The chart structure suggests a bearish short-term trend, with the price facing resistance at its short-term moving averages. Key support levels will be critical to monitor following recent price action. The CCI at -215.94 further suggests downward pressure in the short term.
ProTips
- Monitor insider transactions closely; continued selling could signal underlying concerns despite analyst optimism.
- The stock is trading below key moving averages, suggesting potential for further downside risk in the short term.
- Given the significant projected revenue growth for next year, consider the company's cash burn rate and funding needs to support this expansion.
Key Catalysts
Bullish
Strong Analyst Buy Ratings and Price Targets
Three analysts maintain a 'Buy' rating with a median price target of $13.00, indicating significant upside potential from the current price.
Source: Wall Street AnalystsBullish
Projected Exponential Revenue Growth
Next year's revenue estimates show a projected growth of 275.00%, suggesting a significant ramp-up in business operations.
Source: Wall Street Revenue EstimatesBearish
Moderate Insider Selling Signal
Insiders have sold $19.6 million in stock versus no purchases, indicating a 'Moderate Sell Signal' and potential caution from management.
Source: Insider TransactionsBearish
Negative Earnings Per Share
The company continues to report negative EPS (-1.44), highlighting ongoing profitability challenges.
Source: Company FinancialsMarket Outlook
The base case for ASP Isotopes Inc. (ASPI) over the next 6-12 months hinges on its ability to capitalize on projected substantial revenue growth, with next year's estimates indicating a 275.00% increase. The strong analyst consensus and median price target of $13.00 reflect optimism in the company's long-term potential. However, the thesis could be challenged by continued insider selling and the current lack of profitability, as evidenced by negative EPS. A significant revenue decline in the current year also presents a near-term hurdle. Positive catalysts would include a reversal in insider sentiment, consistent earnings beats, and successful execution of growth strategies to meet ambitious revenue targets.
Key Statistics
| Market Cap | 550.38M |
|---|---|
| P/E Ratio | N/A (Negative EPS) |
| EPS (TTM) | -1.44 |
| Dividend Yield | 0.00% |
| 52 Week High | 14.49 |
| 52 Week Low | 3.51 |
ASP Isotopes Inc. (ASPI) exhibits a negative P/E ratio due to its EPS of -1.44, making traditional valuation metrics difficult to apply. The company's revenue growth was a remarkable 327.6% in the last reported period, significantly outpacing the sector median of 19.0%. However, current year revenue estimates show an expected decline of 8.00% before a projected surge of 275.00% next year. Profitability remains a concern, with a negative EPS and a recent earnings beat on estimates not translating into immediate price gains. The company's balance sheet strength is not detailed, but the significant insider selling warrants caution regarding management's near-term outlook on profitability and valuation.
Earnings & Growth Analysis
ASP Isotopes Inc. (ASPI) most recently reported an EPS of -0.25 on August 14, 2026, which was a 35.9% positive surprise compared to an estimate of -0.39. This beat was followed by a 5.85% price decline. Prior to this, the company missed EPS estimates in July 2026 and beat significantly in May 2026. The pattern suggests volatility in earnings performance relative to expectations.
Key Risks
The primary risk for ASP Isotopes Inc. (ASPI) is the moderate insider selling totaling $19.6 million, indicating potential concerns from management despite the positive analyst outlook. Additionally, the company's current negative EPS and the projected revenue decline for the current year present near-term financial headwinds. Technical indicators also suggest short-term weakness, with the stock trading below key moving averages.
Technical Indicators
| RSI (14) | 41.39 |
|---|---|
| MACD | -0.13 |
| SMA 50 | 4.25 |
| SMA 200 | 5.49 |
RSI
Neutral
SMA Cross
Bearish
Price vs SMA
Bearish
MACD
Bearish
Moving averages show a lagging Death Cross (50-day: $4.245, 200-day: $5.492), price is trading below the 50-day SMA.
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)
+0.39
Weak correlation
Nasdaq 100 (QQQ)
+0.43
Moderate correlation
Bitcoin (BTC)
+0.23
Weak correlation
Gold (XAU)
+0.23
Weak correlation
Check Custom Correlation
Calculating correlation...
ASPI Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative
2%
Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
🟢 LONG ENTRY (click to switch)
CONSERVATIVE
$3.518
2% below current price (Pullback entry)
Lower risk, wait for pullback
AGGRESSIVE
$3.590
Buy at current price
Higher risk, immediate entry
Risk Management
STOP LOSS
$3.157
MAX LOSS
-10.3%
Volatility-Adjusted Stop Loss
Calculated based on RSI (41.4) and current market volatility
Profit Targets (Based on Conservative Entry)
TARGET 1
$3.694
+5% (Conservative)
+2.9% (Aggressive)
TARGET 2
$3.870
+10% (Conservative)
+7.8% (Aggressive)
TARGET 3
$4.046
+15% (Conservative)
+12.7% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Calculate Your Trade
High-Volatility Risk Disclaimer
ASPI is classified as a high-volatility asset (Daily Vol: 4.24%). Aggressive price swings can lead to rapid capital loss. Liquidity risks may prevent exiting trades at desired prices. This AI-generated analysis is for educational purposes only and is not financial advice. Generated on September 11, 2026.Growth of $10,000
A $10,000 investment in ASPI in November 2022 would be worth about $13,446 today, compared with about $19,201 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in ASPI today could grow to about $20,863 by 2036 in the base case, with a bull case near $158,279 and a bear case around $2,750. Projections are statistical simulations, not guarantees.
ASPI Stock Price Prediction: 2030
CleaRank's simulation projects a price near $4.82 for ASPI by 2030 in the base case, from $3.59 today (1.3x over 4 years). The downside path ends near $1.34. These are outcomes of a Monte Carlo simulation run on ASPI's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $2.04 | $3.86 | $7.33 |
| 2028 | $1.68 | $4.16 | $10.29 |
| 2029 | $1.48 | $4.48 | $13.58 |
| 2030 | $1.34 | $4.82 | $17.36 |
| 2031 | $1.24 | $5.19 | $21.73 |
| 2032 | $1.16 | $5.58 | $26.82 |
| 2033 | $1.10 | $6.01 | $32.73 |
| 2034 | $1.06 | $6.47 | $39.60 |
| 2035 | $1.02 | $6.96 | $47.58 |
| 2036 | $0.9872 | $7.49 | $56.82 |
Method: 10,000 simulated price paths using ASPI's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
ASPI Insider Trading Analysis
Bought
None
No open-market buys
Sold
$19.6M
29 Transactions
Insiders
9
Active Traders
Avg Transaction
$674.6K
Moderate size
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Apr 17, 2025 | MANN PAUL ELLIOT
Chief Executive Officer
|
Sell | 950.0K | $5.3M |
| Jun 3, 2026 | MANN PAUL ELLIOT
Chief Executive Officer
|
Sell | 251.3K | $2.0M |
| Sep 9, 2025 | MANN PAUL ELLIOT
Chief Executive Officer
|
Sell | 162.2K | $1.4M |
| Nov 25, 2025 | MANN PAUL ELLIOT
Officer and Director
|
Sell | 162.5K | $1.1M |
| Apr 17, 2025 | AINSCOW ROBERT
Chief Operating Officer
|
Sell | 200.0K | $1.1M |
| Sep 4, 2026 | MANN PAUL ELLIOT
Chief Executive Officer
|
Sell | 251.3K | $999.2K |
| Dec 1, 2025 | MANN PAUL ELLIOT
Officer and Director
|
Sell | 162.2K | $932.9K |
| Mar 2, 2026 | MANN PAUL ELLIOT
Officer
|
Sell | 162.2K | $881.5K |
| Aug 29, 2025 | MOORE DUNCAN
Director
|
Sell | 75.0K | $696.2K |
| Sep 15, 2025 | WIDER TODD
Director
|
Sell | 74.1K | $648.8K |
Page 1 of 1
Frequently Asked Questions
What is ASP Isotopes Inc. stock's current price and rating?
ASP Isotopes Inc. (ASPI) is currently trading at $3.59 per share and holds a 'Buy' consensus rating from analysts.
What is the analyst price target for ASPI stock?
The median analyst price target for ASPI is $13.00, suggesting a potential upside of 262.1% from the current price.
Is ASPI stock experiencing insider selling?
Yes, insiders have been net sellers, with $19.6 million in total sales versus no reported purchases, indicating a moderate sell signal.
What is the revenue growth outlook for ASP Isotopes Inc.?
While the company reported exceptional revenue growth of 327.6% previously, current year estimates project an 8.00% decline, followed by a substantial 275.00% growth projection for next year.
What are the key technical indicators for ASPI stock?
ASPI is trading below its 50-day and 200-day moving averages ($4.25 and $5.49), with neutral RSI momentum (41.39) and a slightly negative MACD, suggesting short-term weakness.
What are the main risks facing ASP Isotopes Inc.?
Key risks include significant insider selling, ongoing negative EPS, and short-term technical weakness, despite a positive long-term revenue outlook and strong analyst conviction.
What is ASPI stock forecast for 2030?
The Monte Carlo simulation for ASPI projects a base case price of $4.82 by 2030, with a downside projection of $1.34 and an upside projection of $17.36. These are statistical outcomes, not guarantees.